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Universal blood pressure (BP) screening in children and adolescents is questioned in prevention guidelines, while measuring
blood pressure in the young in the context of overweight, obesity, or parental hypertension is promoted. This study quantifies
with population data the underestimation of elevated blood pressure that would result from limiting BP screening only to those
with overweight, obesity, or parental hypertension in the young. Selective screening was simulated with representative national
health examination data fromGermany (age 3-17, N=14,633, KiGGS0 study 2003-2006; age 18-39,N=1,884,DEGS1 2008-2011 study),
with mean of two oscillometric measurements on one occasion; cutoffs for hypertensive BP in children were the 95th percentile
using KiGGS percentiles, and for sensitivity analyses Fourth Report percentiles, in adults 140/90mmHg; childhood overweight
and obesity were classified according to the International Obesity Task Force and for adults as BMI ≥25 and ≥30 kg/m2. In 3-
17-year-olds, different selective BP screening scenarios were simulated: screening only in those with obesity, overweight, parental
hypertension, combination of overweight and parental hypertension, resulting in screening 5.6%, 20.0%, 28.5%, and 42.6% of the
population and detecting 17.2%, 38.6%, 30.3%, and 58.2% of all hypertensive cases in the population. In conclusion our results show
a large screening gap that would result from selective BP screening only in those with overweight, obesity, or parental hypertension.
1. Introduction
Blood pressure (BP) screening in children and adolescents is
subject to an ongoing debate [1–8] and is recommended in
hypertension guidelines [7–9] but questioned in prevention
guidelines [2, 3]. BP screening in youth with obvious hyper-
tension risk factors such as obesity has been suggested as a
reasonable selective screening strategy [4] without reference
to the implications of not screening everybody else. In
young adults starting at age 18, universal BP screening is
unequivocally recommended [10–12].However, hypertension
awareness rates in younger adults are rather low compared to
older adults [13], suggesting that adherence to universal BP
screening may be regarded as less important by the young
adults themselves or by their healthcare providers.
Therefore, the aim of our study was to quantify the
population wide underestimation of elevated blood pressure
resulting from selective blood pressure screening in the
young. Data from national health examination surveys in
Germany across a wide age-range of 3-39-year-old partic-
ipants were used to estimate how large the proportion of
the population with undetected elevated BP would be if
only those with overweight, obesity, or parental hypertension
would get their BP measured.
2. Methods
2.1. Study Population. We used data of two recent health
examination surveys in Germany: the German Health Inter-
view and Examination Survey for Adults 2008-2011 (DEGS1)
and the German Health Interview and Examination Survey
for Children and Adolescents 2003-2006 (KiGGS). Both used
a nationwide two-stage-clustered sample design. In the first
step, communities were randomly selected on the basis of
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federal state and community type and size, and in the second
step, a random selection of persons stratified for age and sex
from the local population registers was performed [14, 15].
KiGGS included 14,835 children and adolescents aged
3 to 17 years from 167 communities, of whom 7,570 were
boys and 7,265 were girls. DEGS1 comprised a total of 7,115
adults aged 18-79 years (men: 3,410; women: 3,705) from
180 communities, 1,912 of whom were aged 18-39 years (934
men, 978 women). The studies were approved by the ethical
committee of Charite–University Medicine, Berlin, and by
the Federal Commissioner for Data Protection and Freedom
of Information. Informed written consent and assent were
obtained from all adults and children aged 14 years or older
as well as from parents of children younger than 14 years.
2.2. Measurements and Definitions. BP measurements fol-
lowed a standardized protocol using an automated oscillo-
metric Datascope Accutorr Plus device (Datascope Accutorr
Plus,Mahwah, NJ,USA).Three readings of systolic (SBP) and
diastolic BP (DBP), mean arterial pressure, and pulse rate
were obtained in adults and the second and third measure-
ments were averaged. In children, SBP and DBP from two
readings were averaged. Participants sat upright on a height-
adjustable chair with a backrest, the right forearm was resting
on a table at the level of the heart, the elbowwas slightly bent,
the legs were not crossed, and the feet were placed firmly on
the floor. For determination of the correct cuff size in adults,
the circumference of the upper arm was measured half way
between the acromion and the olecranon and one of three cuff
sizeswere chosen accordingly: cuffwidth 10.5 cmx cuff length
23.9 cm for arm circumferences of 21–27.9 cm, 13.5 × 30.7 cm
for arm circumferences of 28–35.9 cm, and 17 × 38.6 cm for
arm circumferences of 36–46 cm. In children, the cuff had to
cover at least two-thirds of the upper arm length (from the
axilla to the antecubital fossa) and 4 cuffs sizes were available:
6 × 12 cm, 9 × 18 cm, 12 × 23 cm, and 17 × 38.6 cm. The
measurements were realized in 3-minute intervals (children:
2minutes) after a 5-minute rest following a nonstrenuous part
of the examination. A computer-assisted personal interview
included questioning on current and past medical conditions
and medication within the 7 days preceding the interview,
and all medications were coded in accordance with the
WorldHealth Organization’s (WHO’s)AnatomicTherapeutic
Chemical Classification System (ATC code).
Hypertensive BP in children and adolescents was defined
as SBP or DBP ≥95th age- and height-specific percentiles
derived from theKiGGSnonoverweight reference population
according to German guidelines [16, 17]. Thereby, SBP ≥140
or DBP ≥90mm Hg is classified as hypertensive irrespective
of the BP percentile. For a sensitivity analysis, hypertensive
BP in children was defined as SBP or DBP ≥95th age-
and height-specific percentile as recommended by the ESH-
2016 guideline [7] and corresponding to the Fourth Report
percentiles [9].Thereby also SBP ≥140 or DBP ≥90mmHg is
classified as hypertensive irrespective of the BP percentile.
In adults, hypertensive BP wad defined as SBP ≥140
or DBP ≥90mm Hg or on ATC-coded (C02, C03, C07,
C08, C09) antihypertensive medication in case of known,
physician-diagnosed hypertension [13].
Body height and weight measurements were performed
by trained staff according to standardized protocols. Body
height was measured to the nearest 0.1 cm using portable
devices (Harpenden Stadiometer; Holtain Ltd, Crymych,
United Kingdom). Body weight was recorded to the nearest
0.1 kg with the participants dressed only in underwear with-
out shoes and using a calibrated scale (Seca, Birmingham,
United Kingdom). Body Mass Index (BMI) was calculated
as weight in kilogram (kg) divided by height in meter
squared (m2). In adults, the WHO definition was used to
categorize BMI groups as follows: normal-weight for BMI
18.5-24.9 kg/m2, overweight for BMI 25.0-29.9 kg/m2, and
obesity for BMI ≥30.0 kg/m2. In children, overweight and
obesity were defined according to the International Obesity
Task Force (IOTF) [18] and for sensitivity analyses also
according to the German references by Kromeyer-Hauschild
[19].
History of parental hypertension was obtained as part of
the personal medical interview in DEGS1 and by a telephone
follow-up interview conducted from 2009 to 2012 in KiGGS
with the question, “Has the mother or father of the study
participant ever been diagnosed by a doctor as having
hypertension or high BP?” Paternal hypertension status was
unknown for 26.4% of participants aged 18-39 and 18.9% of
those aged 3-17 years, and maternal hypertension status for
22.8% and 13.1%, respectively.
2.3. Analysis. 1,884 adults aged 18-39 years had complete
BP and BMI data (with 98.5% of DEGS participants aged
18-39 years). Complete data on BP and BMI and parental
hypertension were available for 1,482 DEGS participants
(with 77.5% of all participants aged 18-39 years). For children
aged 3 to 17 years, there were 14,633 participants (with 98.6%
of KiGGS participants aged 3 to 17 years) with complete
data for BP and BMI. In each of the eight age and sex
groups (3-6 years, 7-10 years, 11-13 years, and 14-17 years
separately for boys and girls), there were 1,482-2,116 complete
cases, corresponding to 95.9-99.6%of all KiGGS participants,
respectively. 9,229 cases (with 62.2% of KiGGS participants
being 3-17 years old) had complete data BP and BMI and
parental hypertension.
We compared universal BP screening (i.e., measuring BP
in the whole population) to selective screening scenarios,
i.e., measuring BP only in those with overweight, obesity,
or parental hypertension. We calculated common measures
of diagnostic accuracy such as sensitivity, specificity, and
positive and negative predictive value. Taking obesity as “test”
and hypertensive blood pressure as gold standard, sensitivity
was calculated as proportion of obese hypertensives out of all
hypertensives and specificity as proportion of nonobese nor-
motensives out of all normotensives. The positive predictive
value was calculated as proportion of obese hypertensives out
of all obese participants and the negative predictive value as
proportion of nonobese normotensives out of all nonobese
participants.
The KiGGS and DEGS1 data were weighted to the Ger-
man reference population (KiGGS: 31 Dec 2004, DEGS1: 31
Dec 2010) with respect to age, sex, region, and nationality as
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Figure 1: Prevalence of hypertensive BP by age groups.
well as type ofmunicipality. All analyses were performed with
the complex samples option in SPSS 20.0 to take into account
the weighting and the correlation of the participants within a
community.
3. Results
The characteristics of the study population are shown in
Table 1. According to KiGGS percentiles, which are based on
a nonoverweight population from Germany, 10.5% of 3-17-
year-old childrenhad hypertensive BP (boys 11.2%, girls 9.9%)
(Figure 1).
In adults aged 18 to 39 years the prevalence of hyperten-
sive BP was 6.4% (9.9% in men and 2.9% in women).
In hypothetical selective screening scenarios that con-
sist of measuring BP only in children and young adults
with overweight, obesity, or parental hypertension, i.e., at
increased risk of hypertension based on easily available
clinical information, the proportion of the population that
would be screened corresponds to the prevalence of the selec-
tion criterion for screening. The prevalence of overweight
and obesity according to the German reference system, to
IOTF, and to adult cutoffs as well as the prevalence of
parental hypertension is shown in Table 1. For example, if
the screening scenario would be to measure BP only in
obese children (according to IOTF), then 5.6% would have
their BP measured while 94.4% would not. When choosing
overweight or parental history of hypertension as a criterion
formeasuring BP, then 42.6% of children would have their BP
measured. In adults aged 18 to 39 years, obesity as a selection
criterion formeasuring BPwouldmean screening for highBP
in less than one in six adults (13.8%), overweight one in four
adults (26.7%), and parental history of hypertension almost
half of adults (45.3%) (Table 1).
Although the presence of overweight, obesity, or parental
hypertension generally increased the probability of having
hypertensive BP, a large proportion of children with hyper-
tensive BP did not belong to these subgroups. Therefore,
choosing to measure BP only in children with overweight, or
only those with obesity, or only those with parental hyper-
tension would have low sensitivity (Table 2) for detecting
hypertensive BP. Results are reported for overweight and obe-
sity according to the IOTF references but are available upon
request also for German references. For example, measuring
BP only in obese children would detect 17.8% of all boys and
16.4% of all girls with hypertensive BP while well over 80%
of children with hypertensive BP would go undetected since
they are nonobese (Figure 2). Even when measuring BP in all
children with overweight or parental hypertension, over 40%
of cases with hypertensive BP would go undetected. In young
adults, the sensitivity of selective screening in all those with
overweight or parental hypertension was higher and reached
82.5% in men and 94.9% in women. For these results the
German pediatric BP references were used but we report in
the Supplementary Materials the analyses using the Fourth
Report references.
In young adults aged 18-39 years, BP measurements
restricted to overweight would identify 69.4% (95% CI 54.9-
77.9) of men and 73.6% (95% CI 50.7-88.3) of women with
actual hypertension (Figure 2). Screening restricted to obese
adults would detect only 39.4% and 55.7% of hypertensive
men and women, respectively.
Higher sensitivity of selective screening strategies was
associated with lower positive predictive value (Table 2);
e.g., the positive predictive value of overweight or parental
hypertension in women aged 18-39 years for having
hypertensive BP was only 4.2%, while the sensitivity was
94.9%.
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Figure 2: Sensitivity of overweight, obesity, and parental hypertension for detection of hypertensive blood pressure in children (KiGGS-based
definition) and adults (140/90mm Hg cutoff).
Supplemental Table 1 shows the sensitivity of selective
screening strategies stratified by sex and four age groups.
Although there were differences between age groups, the
general pattern of limited sensitivity already apparent for the
overall age group of 3-17 years remained the same.
4. Discussion
Our analysis of population BP data quantifies the population
wide underestimation of elevated blood pressure that would
result from selective BP screening in the young, i.e., from
routine BP measurements only in those with overweight,
obesity, or parental hypertension. The importance of blood
pressure in children has been frequently reported in the
context of the obesity epidemic [2, 4, 20]. As a consequence,
the frequency of BP measurement in ambulatory pediatric
settings is higher in children with overweight and obesity
[21]. Although it is common knowledge that hypertension
does not occur only in the presence of overweight, obesity,
or parental hypertension, there are only very scarce actual
population data quantifying the relevance of the group that
is missed if screening becomes selective [22].
Our analyses show that in children aged 3-17 years,
selective screening of BP only in those with obesity would
fail to detect 82% of cases with hypertensive BP in boys and
84% in girls aged 3-17 years. Even the most sensitive of the
screening scenarios investigated, i.e., screening those with
overweight or parental hypertension, would miss more than
40% of children with hypertensive BP. Of note, irrespective
of the screening strategy, additional BP measurements on
subsequent visits would have to follow before establishing
the diagnosis of hypertension. In children, the prevalence
of hypertensive BP measurements on one occasion is higher
by approximately the factor 4 compared to the prevalence
of hypertension based on hypertensive BP values on three
occasions [23].Whilewe screened for hypertensive BP on one
occasion, a Swiss study with 6th grade students investigated
screening for sustained hypertensive BP over three separate
visits and found only slightly higher sensitivities of targeted
screening based on overweight, obesity, and parental hyper-
tension (including combinations). For example, if only obese
children would participate in the screening, hypertensive BP
on one occasion would be detected only in 20.6% of 11-13-
year-old children according to our study, and hypertension
defined as sustained raised BP on three occasions would be
detected in 24.8% of 10-14-year-old children according to
the Swiss study [22]. The highest sensitivity was achieved
when screening all children with overweight or parental
hypertension (51.7% in our study and 64.6% in the Swiss
study); however, a high proportion of children with raised
BP or, respectively, with hypertension remain undetected.
In accordance with these findings, sustained hypertensive
BP was examined in a 6-year tracking BP study, where
the positive predictive value of obesity at baseline for a
hypertensive BP measurement six years later was 36% in 3-
to 10-year-olds and 50% in 11- to 17-year-olds and for children
International Journal of Hypertension 7
with parental hypertension was 18% and 21%, respectively
[24].
Strengths of our analysis include the large and
population-based sample with BP data based on highly
standardized measurements with one of the few oscillometric
devices validated in children [25, 26]. In the validation study
with children aged 5-15 years the oscillometric Datascope
SBP was 0.9±4.33mmHg lower compared to mercury
sphygmomanometer measurements, DBP 1.2±6.48 lower,
and passed the International Protocol of the European
Society of Hypertension adapted for validation in children
[25, 27]. It is a strength that our BP data are means of two
measurements taken on one occasion, but it is a limitation
that we could not measure BP on several occasions.
Moreover, even with validated oscillometric devices,
guidelines recommend confirmation by auscultatory BP
measurement [7] which was not possible in our study
and represents a limitation. An additional limitation
is the reduced sample size for the analyses concerning
parental hypertension. However, the bias resulting from this
incomplete information is unlikely to change the conclusion
that parental hypertension is not a sufficient criterion for
deciding who should or should not get BP measurements.
A quantitative method to determine the optimal cutoff
value for a screening test is the Receiver Operating Char-
acteristic Curve Analysis. Applied to our study, this would
mean to determine the optimal BMI cutoff for identifying
children and young adults with hypertensive BP. However,
it already becomes evident from the two BMI cutoffs used
in the analysis (defining overweight and defining obesity)
that although the sensitivity increases when the BMI cutoff is
lowered, even when using the overweight cutoff instead of the
obesity cutoff, sensitivity in absolute terms remains moderate
and is insufficient to serve as a screening test.
In summary, our analysis shows with population data
that selective BP screening only in children with obvious
hypertension risk factors such as overweight or parental
hypertension would leave large proportions of children with
elevated BP undetected. This conclusion holds both for
children and young adults and for elevated BP defined by
KiGGS percentiles as well as by Fourth Report percentiles.
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